1AD · ASX

AdAlta Ltd. (ASX:1AD)

AU$0.003

 0.0 (0.0%)
ASX:Live
16/05/2025 02:31:17 PM
Near Support Near 52 Week Low HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

1AD Overview

1AD Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About 1AD

Website

AdAlta Ltd.

Telephone

N/A

Address

Description

AdAlta Ltd. operates as a biotechnology company, discovers, develops, and commercializes protein based therapeutics. The company was founded in 2007 and is headquartered in Bundoora, Australia.

1AD Price Chart

Key Stats

Market Cap

AU$3.22M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.02

Trade Value (12mth)

AU$1,961.00

1 week

-25%

1 month

-40.48%

YTD

-80.16%

1 year

-85.12%

All time high

0.32

Key Fundamentals

EPS 3 yr Growth

-54.50%

EBITDA Margin

N/A

Operating Cashflow

-$5m

Free Cash Flow Return

-261.00%

ROIC

-267.00%

Interest Coverage

-60.90

Quick Ratio

2.40

Other Data

Shares on Issue (Fully Dilluted)

726m

HALO Sector

Healthcare

Next Company Report Date

22-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

1AD Announcements

Latest Announcements

Date Announcements

07 May 25

COMMENCEMENT OF RIGHTS TRADING

×

COMMENCEMENT OF RIGHTS TRADING

07 May 25

Investor Presentation

×

Investor Presentation

05 May 25

Prospectus

×

Prospectus

05 May 25

Update - Proposed issue of securities - 1AD

×

Update - Proposed issue of securities - 1AD

05 May 25

Target Market Determination

×

Target Market Determination

05 May 25

Letter to Optionholders

×

Letter to Optionholders

05 May 25

Letter to Foreign Shareholders

×

Letter to Foreign Shareholders

05 May 25

Update - Proposed issue of securities - 1AD

×

Update - Proposed issue of securities - 1AD

02 May 25

Change of registered address

×

Change of registered address

01 May 25

Quarterly Appendix 4C and Activities Report

×

Quarterly Appendix 4C and Activities Report

01 May 25

Renounceable Rights Issue to Raise up to $1.3 million

×

Renounceable Rights Issue to Raise up to $1.3 million

01 May 25

Proposed issue of securities - 1AD

×

Proposed issue of securities - 1AD

30 April 25

Trading Halt

×

Trading Halt

14 April 25

Notification of cessation of securities - 1AD

×

Notification of cessation of securities - 1AD

14 April 25

Notification regarding unquoted securities - 1AD

×

Notification regarding unquoted securities - 1AD

26 March 25

ASX Emerging Gems presentation

×

ASX Emerging Gems presentation

20 March 25

SYNBV invest up to $2m in East to West subsidiary

×

SYNBV invest up to $2m in East to West subsidiary

17 March 25

Application for quotation of securities - 1AD

×

Application for quotation of securities - 1AD

17 March 25

Cleansing Notice

×

Cleansing Notice

13 March 25

Investor presentation - Stocks on Track

×

Investor presentation - Stocks on Track

05 March 25

R&D Tax Incentive advance received

×

R&D Tax Incentive advance received

04 March 25

Company presentation - East-West Biopharma Summit

×

Company presentation - East-West Biopharma Summit

21 February 25

Application for quotation of securities - 1AD

×

Application for quotation of securities - 1AD

21 February 25

Cleansing Notice

×

Cleansing Notice

20 February 25

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

11 February 25

Webinar presentation - East to West cell therapy strategy

×

Webinar presentation - East to West cell therapy strategy

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

%

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

1AD Shortsell

Frequently Asked Questions

The current share price of AdAlta Ltd. (1AD:ASX) is AU$0.003.
The 52-week high share price for AdAlta Ltd. (1AD:ASX) is AU$0.02.
The 52-week low share price for AdAlta Ltd. (1AD:ASX)? is AU$0.00.
AdAlta Ltd. (1AD:ASX) does not pay a dividend.
AdAlta Ltd. (1AD:ASX) does not pay a dividend.
AdAlta Ltd. (1AD:ASX) does not offer franking credits.
AdAlta Ltd. (1AD:ASX) is classified in the Healthcare.
The current P/E ratio for AdAlta Ltd. (1AD:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.